111 related articles for article (PubMed ID: 10427139)
1. Frequency and pattern of p53 gene mutation in a cohort of Spanish women with node-negative breast cancer.
Meng L; Lin L; Fresno M; Morales AR; Nadji M
Int J Oncol; 1999 Sep; 15(3):555-8. PubMed ID: 10427139
[TBL] [Abstract][Full Text] [Related]
2. Multiple mutations of the p53 gene in human mammary carcinoma.
Meng L; Lin L; Zhang H; Nassiri M; Morales AR; Nadji M
Mutat Res; 1999 Dec; 435(3):263-9. PubMed ID: 10606817
[TBL] [Abstract][Full Text] [Related]
3. Pattern of p53 gene mutations in breast cancers of women of the midwestern United States.
Sommer SS; Cunningham J; McGovern RM; Saitoh S; Schroeder JJ; Wold LE; Kovach JS
J Natl Cancer Inst; 1992 Feb; 84(4):246-52. PubMed ID: 1734086
[TBL] [Abstract][Full Text] [Related]
4. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
6. The timing and characterization of p53 mutations in progression from atypical ductal hyperplasia to invasive lesions in the breast cancer.
Kang JH; Kim SJ; Noh DY; Choe KJ; Lee ES; Kang HS
J Mol Med (Berl); 2001 Nov; 79(11):648-55. PubMed ID: 11715068
[TBL] [Abstract][Full Text] [Related]
7. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
[TBL] [Abstract][Full Text] [Related]
8. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.
Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR
Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522
[TBL] [Abstract][Full Text] [Related]
10. Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers.
Pollett A; Bedard YC; Li SQ; Rohan T; Kandel R
Mod Pathol; 2000 Nov; 13(11):1173-9. PubMed ID: 11106073
[TBL] [Abstract][Full Text] [Related]
11. Low frequency of p53 gene mutations in breast cancers of Japanese-American women.
Buzin CH; Tang SH; Cunningham JM; Shibata A; Ross RK; Hartmann A; Blaszyk H; Kovach JS
Nutr Cancer; 2001; 39(1):72-7. PubMed ID: 11588905
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.
Thor AD; Moore DH II; Edgerton SM; Kawasaki ES; Reihsaus E; Lynch HT; Marcus JN; Schwartz L; Chen LC; Mayall BH
J Natl Cancer Inst; 1992 Jun; 84(11):845-55. PubMed ID: 1317462
[TBL] [Abstract][Full Text] [Related]
13. p53 Mutation analysis in breast tumors by a DNA microarray method.
Tennis M; Krishnan S; Bonner M; Ambrosone CB; Vena JE; Moysich K; Swede H; McCann S; Hall P; Shields PG; Freudenheim JL
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):80-5. PubMed ID: 16434591
[TBL] [Abstract][Full Text] [Related]
14. TP53 mutations in primary breast carcinomas from white and African-Brazilian patients.
Nagai MA; Schaer Barbosa H; Zago MA; Araújo Silva W; Nishimoto IN; Salaorni S; Guerreiro Costa LN; Silva Araújo M; Caldas Oliveira AG; Mourâo Neto M; Brentani MM
Int J Oncol; 2003 Jul; 23(1):189-96. PubMed ID: 12792793
[TBL] [Abstract][Full Text] [Related]
15. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
16. G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.
Kouidou S; Malousi A; Kyventidis A; Fragou A; Maglaveras N
Breast Cancer Res Treat; 2007 Dec; 106(3):351-60. PubMed ID: 17505880
[TBL] [Abstract][Full Text] [Related]
17. p53 gene alterations in special types of breast carcinoma: a molecular and immunohistochemical study in archival material.
Karameris AM; Worthy E; Gorgoulis VG; Quezado M; Anastassiades OT
J Pathol; 1995 Aug; 176(4):361-72. PubMed ID: 7562251
[TBL] [Abstract][Full Text] [Related]
18. Frequency of spontaneous p53 mutations (CpG site) in breast cancer in Japan.
Sasa M; Kondo K; Komaki K; Uyama T; Morimoto T; Monden Y
Breast Cancer Res Treat; 1993 Sep; 27(3):247-52. PubMed ID: 8312582
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations and overexpression in locally advanced breast cancers.
Faille A; De Cremoux P; Extra JM; Linares G; Espie M; Bourstyn E; De Rocquancourt A; Giacchetti S; Marty M; Calvo F
Br J Cancer; 1994 Jun; 69(6):1145-50. PubMed ID: 8198984
[TBL] [Abstract][Full Text] [Related]
20. P53 gene mutations in women with breast cancer and a previous history of benign breast disease.
Seth A; Palli D; Mariano JM; Metcalf R; Venanzoni MC; Bianchi S; Kottaridis SD; Papas TS
Eur J Cancer; 1994; 30A(6):808-12. PubMed ID: 7917542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
